No Data
No Data
SeaStar Medical Granted Two New BDD for SCD Therapy by FDA
Express News | FDA Grants SeaStar Medical Two New Breakthrough Device Designations for Scd Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
Maxim Group Maintains SeaStar Medical(ICU.US) With Buy Rating, Announces Target Price $7
SeaStar Medical Holdings: Buy Rating Driven by Clinical Milestones and Market Expansion Opportunities
SeaStar Medical Holding Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results.
Express News | SeaStar Medical Holding Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results